Cas:38323-22-7 dimethyl 2-[(4-nitrophenyl)methylidene]propanedioate manufacturer & supplier

We serve Chemical Name:dimethyl 2-[(4-nitrophenyl)methylidene]propanedioate CAS:38323-22-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

dimethyl 2-[(4-nitrophenyl)methylidene]propanedioate

Chemical Name:dimethyl 2-[(4-nitrophenyl)methylidene]propanedioate
CAS.NO:38323-22-7
Synonyms:Propanedioic acid,[(4-nitrophenyl)methylene]-,dimethyl ester;dimethyl (4-nitrobenzylidene)-malonate;dimethyl (p-nitrobenzylidene)malonate;Dimethyl 2-(4-nitrobenzylidene)malonate;1,3-dimethyl 2-(4-nitrobenzylidene)malonate;dimethyl 2-[(4-nitrophenyl)methylene]propane-1,3-dioate;2-Carbomethoxy-3-(4-nitrophenyl)propenoic acid methyl ester;MFCD00074999
Molecular Formula:C12H11NO6
Molecular Weight:265.21900
HS Code:2917399090

Physical and Chemical Properties:
Melting point:137-139ºC(lit.)
Boiling point:336.4ºC at 760 mmHg
Density:1.335g/cm3
Index of Refraction:1.578
PSA:98.42000
Exact Mass:265.05900
LogP:1.84740

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Propanedioic acid,[(4-nitrophenyl)methylene]-,dimethyl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00074999 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Dimethyl 2-(4-nitrobenzylidene)malonate Use and application,dimethyl 2-[(4-nitrophenyl)methylene]propane-1,3-dioate technical grade,usp/ep/jp grade.


Related News: With the closing of AstraZeneca’s mega $39 billion buyout of Alexion Pharmaceuticals this week, the U.K. pharma has officially picked up Soliris and its successor, Ultomiris. (2R)-propane-1,2-diamine,sulfuric acid manufacturers The role of a trusted contract development and manufacturing organization (CDMO), with long-standing record of regulatory compliance and efficient project management, can help tremendously in reduced time and costs for the early phase development and commercialization of small molecule active pharmaceutical ingredients (APIs) in the pharmaceutical industry, according to experts. Bis(hexamethylene)triamine suppliers developing a New Deal for post-graduate research students, starting later this year with a cross-sectoral consultation led by UKRI 1496552-52-3 vendor & factory.